Keyword search

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Type

1 facets displayed. 0 facets selected.

Year of publication

1 facets displayed. 1 facets selected.

Geography

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (4)

All (4) ((4 results))

  • Articles and reports: 88F0006X2002003
    Description:

    This is the final of three papers providing data and an overview of the results of the Biotechnology Use and Development Survey - 1999. Readers are encouraged to use the data. The next edition of the Biotechnology Use and Development Survey - 2001 is expected to be administered in the spring of 2002 with results available early in 2003.

    Release date: 2002-03-28

  • Articles and reports: 88F0006X2002004
    Description:

    Spin-off firms made up over 34% of the core group of firms from the 1999 biotechnology survey. They also made up over 112 of the 270 small (under 50 employees) size firms, by far the largest group of core biotechnology, and half of the human health related firms, the largest sector of biotechnology firms. Central to this paper is the question: What are the general characteristics of this sub-group of core biotechnology firms?

    Release date: 2002-03-28

  • Articles and reports: 88-003-X20020016146
    Geography: Canada
    Description:

    This, the first issue of 2002 presents an opportunity to recapitulate some of the findings that we have reported during the life of the Bulletin. In an interview, Dr. Fred Gault, Director of Statistics Canada's Science, Innovation and Electronic Information Division, discusses some of the findings on innovation, e-commerce, emerging technologies, Internet use, the telecommunications industry, R&D and commercialization.

    Release date: 2002-02-15

  • Articles and reports: 88-003-X20020016149
    Geography: Canada
    Description:

    According to the report Profile of Spin-off Firms in the Biotechnology Sector, three out of every 10 companies in Canada's rapidly expanding biotechnology sector in 1999 were spin-offs. These firms, which range from corporate spin-offs to biotechnology companies created by universities and research hospitals, accounted for more than one-quarter of total revenues in 1999.

    Release date: 2002-02-15
Data (0)

Data (0) (0 results)

No content available at this time.

Analysis (4)

Analysis (4) ((4 results))

  • Articles and reports: 88F0006X2002003
    Description:

    This is the final of three papers providing data and an overview of the results of the Biotechnology Use and Development Survey - 1999. Readers are encouraged to use the data. The next edition of the Biotechnology Use and Development Survey - 2001 is expected to be administered in the spring of 2002 with results available early in 2003.

    Release date: 2002-03-28

  • Articles and reports: 88F0006X2002004
    Description:

    Spin-off firms made up over 34% of the core group of firms from the 1999 biotechnology survey. They also made up over 112 of the 270 small (under 50 employees) size firms, by far the largest group of core biotechnology, and half of the human health related firms, the largest sector of biotechnology firms. Central to this paper is the question: What are the general characteristics of this sub-group of core biotechnology firms?

    Release date: 2002-03-28

  • Articles and reports: 88-003-X20020016146
    Geography: Canada
    Description:

    This, the first issue of 2002 presents an opportunity to recapitulate some of the findings that we have reported during the life of the Bulletin. In an interview, Dr. Fred Gault, Director of Statistics Canada's Science, Innovation and Electronic Information Division, discusses some of the findings on innovation, e-commerce, emerging technologies, Internet use, the telecommunications industry, R&D and commercialization.

    Release date: 2002-02-15

  • Articles and reports: 88-003-X20020016149
    Geography: Canada
    Description:

    According to the report Profile of Spin-off Firms in the Biotechnology Sector, three out of every 10 companies in Canada's rapidly expanding biotechnology sector in 1999 were spin-offs. These firms, which range from corporate spin-offs to biotechnology companies created by universities and research hospitals, accounted for more than one-quarter of total revenues in 1999.

    Release date: 2002-02-15
Reference (0)

Reference (0) (0 results)

No content available at this time.

Date modified: